This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Owens, D.G.C. Articles by Johnstone, E. C. Search for Related Content PubMed Articles by Owens, D.G.C. Articles by Johnstone, E. C. Social Bookmarking                         What's this?

L-dopa helps positive but not negative features of neuroleptic-insensitive chronic schizophrenia

Department of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Morningside Park, Edinburgh EH10 5HF

P.E. Harrison-Read

Department of Mental Health, Central Middlesex Hospital, Acton Lane, London NW10 7NS, UK

Eve C. Johnstone

Department of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Morningside Park, Edinburgh EH10 5HF

L-dopa (Sinemet-110 in a final dose equivalent to — 4 g per day) added to maintenance chlorpromazine, produced a small antipsychotic effect in a group of eight severely impaired male chronic schizophrenic in-patients. Negative symptoms were unaffected by L-dopa, although the improvement in psychotic behaviour and positive symptoms was restricted to the four patients with the most severe negative symptoms measured during the control treatment period. These L-dopa responders also tended to improve slightly when the dose of chlorpromazine was halved, an indication of their poor, or even counter-therapeutic response to conventional neuroleptic medication given in relatively high dosage. Signs of increased dopaminergic activity (raised eye blink rate and reduced plasma prolactin) were not observed in subjects showing an antipsychotic response to L-dopa. This raises the possibility that L-dopa may exert an antipsychotic effect in neuroleptic-insensitive subjects by altering noradrenergic activity in the brain.

Key Words: L-dopa • neuroleptic insensitive • schizophrenic • positive symptoms • noradrenergic activity

Journal of Psychopharmacology, Vol. 8, No. 4, 204-212 (1994)
DOI: 10.1177/026988119400800403


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?